Regression rate of choroidal melanoma following iodine-125 brachytherapy is not associated with metastatic spread

MLA

Juliette Thariat, et al. “Regression Rate of Choroidal Melanoma Following Iodine-125 Brachytherapy Is Not Associated with Metastatic Spread.” Melanoma Research, vol. 29, June 2019, pp. 295–300. EBSCOhost, https://doi.org/10.1097/cmr.0000000000000540.

APA

Juliette Thariat, Frédéric Mouriaux, Anne-Sophie Julien, Solange Landreville, Ioana Fugaru, Nadia Lihimdi, & François Pépin. (2019). Regression rate of choroidal melanoma following iodine-125 brachytherapy is not associated with metastatic spread. Melanoma Research, 29, 295–300. https://doi.org/10.1097/cmr.0000000000000540

Chicago

Juliette Thariat, Frédéric Mouriaux, Anne-Sophie Julien, Solange Landreville, Ioana Fugaru, Nadia Lihimdi, and François Pépin. 2019. “Regression Rate of Choroidal Melanoma Following Iodine-125 Brachytherapy Is Not Associated with Metastatic Spread.” Melanoma Research 29 (June): 295–300. doi:10.1097/cmr.0000000000000540.